Sheldon L. Holder
Impact in
-
- Cancer Mechanisms and Therapy
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in
- Surgery 21
- Bladder and Urothelial Cancer Treatments 21
- Urinary and Genital Oncology Studies 9
-
- Renal cell carcinoma treatment 8
- Advanced Breast Cancer Therapies 3
- Co-authors
- Michael B. Lilly (4 shared papers)Marina Zemskova (3 shared papers)Joseph J. Drabick (23 shared papers)Monika Joshi (22 shared papers)Matthew Kaag (10 shared papers)Ming Yin (7 shared papers)Elisabeth E. Fransen van de Putte (1 shared paper)Richard P. Meijer (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)Cancer Research (5 papers)Clinical Genitourinary Cancer (3 papers)Oncotarget (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Sheldon L. Holder
40 papers receiving 1.0k citations
Sheldon L. Holder's Hit Papers
Peers
Comparison fields: 5 of 70
- Pathology and Forensic Medicine 341
- Oncology 341
- Surgery 371
- Urology 37
- Hematology 52
Countries citing papers authored by Sheldon L. Holder
This map shows the geographic impact of Sheldon L. Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon L. Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon L. Holder more than expected).
Fields of papers citing papers by Sheldon L. Holder
This network shows the impact of papers produced by Sheldon L. Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon L. Holder. The network helps show where Sheldon L. Holder may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheldon L. Holder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis Hit paper breakdown → | 2016 | 325 |
| 2 | 2003 | 216 | |
| 3 | 2007 | 159 | |
| 4 | 2014 | 38 | |
| 5 | 2007 | 34 | |
| 6 | 2017 | 32 | |
| 7 | 2022 | 30 | |
| 8 | 2015 | 25 | |
| 9 | 2023 | 19 | |
| 10 | 2015 | 15 | |
| 11 | 2019 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2015 | 12 | |
| 15 | 2015 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2018 | 10 | |
| 18 | Clinical features of patients with MTAP-deleted bladder cancer. | 2023 | 8 |
| 19 | 2020 | 6 | |
| 20 | 2018 | 6 |
About Sheldon L. Holder
Sheldon L. Holder is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (21 papers), Cancer Mechanisms and Therapy (10 papers), Urinary and Genital Oncology Studies (9 papers), Renal cell carcinoma treatment (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (341 citations), Oncology (341 citations), Surgery (371 citations), Urology (37 citations) and Hematology (52 citations). Sheldon L. Holder has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Michael B. Lilly, Marina Zemskova, Joseph J. Drabick, Monika Joshi, Matthew Kaag, Ming Yin, Elisabeth E. Fransen van de Putte, Richard P. Meijer, Simon Horenblas and Harold A. Harvey. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Genitourinary Cancer, Oncotarget and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.